Physician profile
Matthew Woolley
NPI 1245201136
$7,734.75
in general payments reported to CMS, 2019-2025
40 companies · $1,737 in 2025
The $1,737 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $221 · 2021: $535 · 2022: $1,262 · 2023: $1,422 · 2024: $1,431 · 2025: $1,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,393 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,392.70 |
| Education | $197.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,291.49 | 2019-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $1,111.88 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $687.77 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $619.90 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $614.58 | 2019-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $326.70 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $292.21 | 2019-2025 | |
| Telix Pharmaceuticals | $261.10 | 2024-2025 | Illuccix |
| Myovant Sciences INC. | $251.78 | 2021-2022 | |
| Pfizer INC. | $248.45 | 2019-2025 | |
| Boston Scientific Corporation | $226.76 | 2019-2023 | Varithena Administration Pack |
| Tolmar, INC. | $197.78 | 2024-2025 | Eligard, Jatenzo |
| Progenics Pharmaceuticals, INC. | $177.04 | 2021-2025 | Pylarify |
| Teleflex LLC | $160.20 | 2022-2023 | Urolift |
| Accord Healthcare, INC. | $144.02 | 2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $126.23 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $116.88 | 2022-2024 | Lynparza, Keytruda, Welireg |
| Endo Pharmaceuticals INC. | $104.79 | 2019-2023 | Aveed, Xiaflex |
| Coloplast Corp | $95.84 | 2019-2024 | |
| Urovant Sciences INC | $68.05 | 2021-2022 | |
| Endo USA, INC. | $62.34 | 2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $61.92 | 2024-2025 | |
| Blue Earth Diagnostics | $45.26 | 2019 | |
| Acerus Pharmaceuticals Corporation | $43.73 | 2022 | |
| Azurity Pharmaceuticals, INC. | $37.02 | 2025 | Azmiro |
| Hollister Incorporated | $36.29 | 2019-2021 | |
| Antares Pharma, INC. | $34.35 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Amgen INC. | $34.20 | 2019-2022 | |
| Olympus America INC. | $31.20 | 2025 | Itind System |
| Procept Biorobotics Corporation | $28.44 | 2024 | Aquabeam System |
| Immunitybio, INC. | $27.90 | 2025 | |
| Dentsply Ih INC. | $26.33 | 2021-2022 | |
| Mission Pharmacal Company | $23.02 | 2022 | |
| Axonics, INC. | $21.59 | 2023 | Bulkamid |
| Myriad Genetic Laboratories, INC. | $19.24 | 2025 | Prolaris |
| Travere Therapeutics, INC. | $18.96 | 2021 | |
| Verity Pharmaceuticals INC. | $17.12 | 2023 | Trelstar |
| Dentsply Ih Ab | $14.58 | 2025 | Lofric |
| 180 Medical, INC. | $14.24 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Woolley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.